Epilepsy Canada boosts the next generation of epilepsy researchers.

Epilepsy Canada has awarded two one-time research bursaries under its Summer Studentships Program. The recipients are Owen Wiseman of the University of Ottawa and Sophie Ehresmann of the Université de Montréal.

The purpose of Epilepsy Canada’s summer bursary program is to encourage outstanding students to pursue careers in epilepsy: in research or practice settings. The bursaries are intended for third and fourth year undergraduates earning a B.Sc., graduates in psychology, sociology, biochemistry and medicine.

Ms. Sophie Ehresmann, BA Biochemistry and Molecular Medicine studies described the support from Epilepsy Canada as “Amazing!” Ms. Ehresmann is working at CHU St Justine Montréal under the supervision of Dr. Phillippe Campeau. Recent work there has identified an epileptic syndrome apparently caused by mutations of a gene never before associated with the disorder. The Epilepsy Canada grant will help the study team confirm that the suspected mutations can in fact lead to epilepsy. This will lead to a number of positive outcomes to improve diagnosis and treatment

Mr. Owen Wiseman, BSc – Psychology, is examining the effects of a motivational exercise program, using peer-to-peer support, to increase physical activity and improve the quality of life for children with epilepsy. He is working on the study under the supervision of Daniela Pohl MD PHD at the Children’s Hospital of Eastern Ontario. He commented, “People’s behavior has always interested me, so neurology became the only career choice for me as I progressed with my education.”

The results from both studies are expected to be known in late 2015.

Renée Colyer, CEO of Forefactor Consulting, appointed to Epilepsy Canada Board of Directors

Jacques Brunelle, President of Epilepsy Canada is pleased to announce the appointment of Renée Colyer to the Board of Directors of Epilepsy Canada, effective immediately.

Ms. Colyer is the President and CEO of Forefactor Consulting where she is focused on providing business strategy and research to capital market participants in both developing countries and mature markets. She possesses extensive knowledge of the, insurance, capital markets and banking sectors. Prior to founding Forefactor Ms. Colyer held the position of Director of Research at TSX Group.

With Epilepsy Canada, Renée Colyer will apply her management skills and broad financial services knowledge to the role of Corporate Donor & Major Gift Advocate. She will advise and assist the Epilepsy Canada team to meet its growth targets from major gifts and corporate donors.

Ms. Colyer is a graduate of Guelph University and holds a Post-Baccalaureate Diploma in Market Research Analysis from the Sheridan Institute and a Certificate in Market Research from the University Notre Dame. In addition, she holds memberships in the United Nations Registry, the World Association of Opinion and Marketing Research Professionals,(ESOMAR). Epilepsy Canada is a non-profit organization whose mission is to enhance the quality of life for persons affected by the neurological disorder. It promotes the support of research and facilitates education and awareness initiatives that build understanding and acceptance of epilepsy.

Founded in 1966, Epilepsy Canada has a legacy of continuous support for epilepsy research.